The reduction in HBsAg levels from baseline at week 48 in the Add-on group was negatively correlated with the increase in serum IP-10 levels at week 12, but did not reach statistical significance ( r = −0.225, p = 0.068, Fig. 3 B).
← all excerpts
Serum IP-10 increase correlated with PEG-IFNα response in nucleot(s)ide analogs-treated patients with chronic hepatitis B.
1
0.0680
0.0680